1. MARKETS
  2. SECTOR : HEALTHCARE & MEDICAL EQUIPMENT SUPPLIERS
  3. INDUSTRY : MEDICAL DISTRIBUTORS
  4. DATAMEDS AI INC.
DataMEDS AI Inc.
XNAS: MEDS
Download real time
2.96 -0.44 (-12.94%)
95.95% Fall from 52W High
458.6K
XNAS Volume

XNAS 09 Oct, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert


Insider Trading disclosures for DataMEDS AI Inc

The latest disclosure was made by Surendra K. Ajjarapu in DataMEDS AI Inc where a trade of 100,000 Common Stock done at an average price of $0.0 was reported to US exchanges on June 22, 2026.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Surendra K. Ajjarapu Director 22 Jun 2026 100,000 257,645 - 0.0 500 Common Stock
Surendra K. Ajjarapu Director 22 Jun 2026 100,000 0 - - Warrant
Surendra K. Ajjarapu Director Grant, award, or other acquisition of securities at price $ 0.20 per share. 31 Mar 2026 5,000,000 7,882,247 - 0.2 1,000,000 Common Stock
Surendra K. Ajjarapu Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2026 5,000,000 5,000,000 - - Warrant
Surendra K. Ajjarapu Director Grant, award, or other acquisition of securities at price $ 0.20 per share. 31 Mar 2026 5,000,000 7,882,247 - 0.2 1,000,000 Common Stock
Surendra K. Ajjarapu Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2026 5,000,000 5,000,000 - - Warrant
Michael L. Peterson Director Grant, award, or other acquisition of securities at price $ 0.90 per share. 02 Jul 2025 200,000 200,000 - 0.9 180,000 Common Stock
Rebecca Shanahan Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Mar 2025 200,000 244,720 - 0 Common Stock, Par Value $0.0001
Surendra K. Ajjarapu Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Mar 2025 600,000 3,100,000 - 0 Common Stock, Par Value $0.0001
Surendra K. Ajjarapu Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Mar 2025 600,000 4,463,200 - 0 Common Stock, Par Value $0.0001
Surendra K. Ajjarapu Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Mar 2025 2,882,247 1,822,247 - 0 Common Stock, Par Value $0.0001
Nikul Panchal Chief Pharmacy Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Mar 2025 90,000 90,000 - 0 Common Stock, Par Value $0.0001
Shafaat Pirani Chief Clinical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Mar 2025 35,000 102,080 - 0 Common Stock, Par Value $0.0001
Brian Norton Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Mar 2025 9,000,000 9,044,720 - 0 Common Stock, Par Value $0.0001
Sajid Syed Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Mar 2025 200,000 244,720 - 0 Common Stock, Par Value $0.0001
Donald W. Anderson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Mar 2025 200,000 244,720 - 0 Common Stock, Par Value $0.0001
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters